275 related articles for article (PubMed ID: 22238189)
1. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
[TBL] [Abstract][Full Text] [Related]
2. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
[TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic right ventricular dysplasia: a United States experience.
Dalal D; Nasir K; Bomma C; Prakasa K; Tandri H; Piccini J; Roguin A; Tichnell C; James C; Russell SD; Judge DP; Abraham T; Spevak PJ; Bluemke DA; Calkins H
Circulation; 2005 Dec; 112(25):3823-32. PubMed ID: 16344387
[TBL] [Abstract][Full Text] [Related]
7. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey.
Versteeg H; Starrenburg A; Denollet J; Palen Jv; Sears SF; Pedersen SS
Pacing Clin Electrophysiol; 2012 Mar; 35(3):283-93. PubMed ID: 22229519
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in anxiety and concerns about the cardioverter defibrillator.
Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
[TBL] [Abstract][Full Text] [Related]
10. Age-specific differences in women with implantable cardioverter defibrillators: an international multi center study.
Vazquez LD; Kuhl EA; Shea JB; Kirkness A; Lemon J; Whalley D; Conti JB; Sears SF
Pacing Clin Electrophysiol; 2008 Dec; 31(12):1528-34. PubMed ID: 19067804
[TBL] [Abstract][Full Text] [Related]
11. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
12. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients.
Pedersen SS; Spindler H; Johansen JB; Mortensen PT; Sears SF
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1168-77. PubMed ID: 18834469
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
[TBL] [Abstract][Full Text] [Related]
15. Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Ma KJ; Li N; Wang HT; Chu JM; Fang PH; Yao Y; Ma J; Hua W; Zhang S; Wang FZ; Li Z; Pu JL
Chin Med J (Engl); 2009 May; 122(10):1133-8. PubMed ID: 19493458
[TBL] [Abstract][Full Text] [Related]
16. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
Udlis KA
J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
[TBL] [Abstract][Full Text] [Related]
17. Clustering of poor device acceptance and Type D personality is associated with increased distress in Danish cardioverter-defibrillator patients.
Pedersen SS; Spindler H; Johansen JB; Mortensen PT
Pacing Clin Electrophysiol; 2009 Jan; 32(1):29-36. PubMed ID: 19140910
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
[TBL] [Abstract][Full Text] [Related]
19. Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex.
Rhodes AC; Murray B; Tichnell C; James CA; Calkins H; Sears SF
Int J Cardiol; 2017 Dec; 248():216-220. PubMed ID: 28823501
[TBL] [Abstract][Full Text] [Related]
20. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey.
Burns JL; Serber ER; Keim S; Sears SF
J Cardiovasc Electrophysiol; 2005 Apr; 16(4):384-90. PubMed ID: 15828880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
